Scarica l'app Stockscreener
55.52
12.36%
-7.83
Pre-mercato:
56.90
1.38
+2.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Reports Strong Growth Amid Challenges - TipRanks
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces - GlobeNewswire
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
HIMS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages - GlobeNewswire
Shareholders of Hims & Hers Health, Inc. Should Contact - GlobeNewswire
US Market Under Pressure: Amazon, Eastman Chemical, and Hims & Hers Among Top Losers - FinancialContent
Why Hims & Hers Health (HIMS) Faces New Questions After Revenue Guidance Miss and Regulatory Setbacks - simplywall.st
Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem. - Barron's
Wait Out The GLP-1 Storm – Buy The Hims And Hers Post-Earnings Dip (NYSE:HIMS) - Seeking Alpha
Hims & Hers Stock Is Trading Lower Tuesday: What's Going On? - Benzinga
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers Stock Sags As Revenue Falls Short Of Hype - Finimize
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down - Yahoo Finance
Palantir, Pfizer, Vertex, Hims & Hers, BP, and More Stock Market Movers - Barron's
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
Hims & Hers Health Posts Weak Q2; Heading Into More Near-Term Challenges, Analysts Say - Benzinga
Why Hims & Hers Health Stock Just Dropped - Nasdaq
Hims & Hers Health, DuPont, Gartner: Trending Tickers - Yahoo Finance
Hims & Hers stock slides 5% after second quarter revenue misses forecasts - Yahoo Finance
Hims & Hers Hits $1.5B Revenue, Eyes $2.4B in 2025 with AI Telehealth - WebProNews
Hims & Hers Q2 EarningsWall Street Sells Despite GLP Compounding Promises (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Mixed Q2 Results Signal Valuation Concerns - Trefis
Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth - Yahoo Finance
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar
Earnings live: Palantir stock pops on raised outlook, Hims & Hers tumbles - Yahoo Finance
Hims & Hers: Buy The Core Engine, Not The Headline (NYSE:HIMS) - Seeking Alpha
Hold Rating for Hims & Hers Health Amid Mixed Results and Growth Investments - TipRanks
Hims & Hers: Buy The Earnings Dip, Slowly (Rating Downgrade) (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? - Benzinga
Avantax Advisory Services Inc. Sells 5,127 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health Inc (HIMS) Q2 2025 Earnings Call Highlights: Robust Revenue Growth Amid ... - Yahoo Finance
Hims & Hers Health Reports Strong Q2 2025 Growth - TipRanks
Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Hims & Hers: Scaling the Future of Digital Health and Capturing a $2 Trillion Wellness Market - AInvest
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - Stockhouse
Cautious Outlook for Hims & Hers Health Amid Revenue Shortfall and Adjusted Guidance - TipRanks
Earnings call transcript: Hims Hers Health Q2 2025 beats EPS forecasts - Investing.com
Hims & Hers Health Stock Stumbles After Earnings. Here’s Why. - Barron's
Hims & Hers Health, Inc. (HIMS) Misses Q2 Earnings and Revenue Estimates - Yahoo Finance
Hims & Hers, ThredUp, MercadoLibre: After-hours trending stocks - Yahoo Finance
Hims & Hers stock drops after Q2 revenue miss (HIMS:NYSE) - Seeking Alpha
Hims & Hers Health Reports Higher Profit, Revenue - The Wall Street Journal
Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12% - Yahoo Finance
Hims & Hers stock falls 10% on revenue miss - CNBC
Hims & Hers Tumbles On Q2 Miss, Highlights Growth ProspectsHims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers Health, Inc. Sued for Securities Law Violations - GlobeNewswire
Hims & Hers Health Reports Strong Q2 2025 Financial Growth - TipRanks
HIMS Earnings: Hims & Hers Health Stock Tanks on Mixed Q2 Results - TipRanks
Investing in the Future of Healthcare - Hims & Hers Newsroom
Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results - Yahoo Finance
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - MSN
Hims & Hers Health, Inc. (HIMS)Lawmakers Urge Crackdown - GlobeNewswire
Investor Alert: Deadline Approaching to Join Hims & Hers Health, Inc. (HIMS) Class ActionContact Levi & Korsinsky - The Globe and Mail
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT - GlobeNewswire
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) Shareholders of Class Action Lawsuit and August 25, 2025 Deadline - ACCESS Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - MarketScreener
HIMS Investors Have Opportunity To Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - Barchart.com
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
0.95%
5.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):